Opin vísindi

Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study

Skoða venjulega færslu

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Song, Huan
dc.contributor.author Fang, Fang
dc.contributor.author Valdimarsdottir, Unnur
dc.contributor.author Lu, Donghao
dc.contributor.author Andersson, Therese M.-L.
dc.contributor.author Hultman, Christina
dc.contributor.author Ye, Weimin
dc.contributor.author Lundell, Lars
dc.contributor.author Johansson, Jan
dc.contributor.author Nilsson, Magnus
dc.contributor.author Lindblad, Mats
dc.date.accessioned 2017-06-14T15:20:17Z
dc.date.available 2017-06-14T15:20:17Z
dc.date.issued 2017-01-03
dc.identifier.citation Song, H., Fang, F., Valdimarsdóttir, U., Lu, D., Andersson, T. M.-L., Hultman, C., . . . Lindblad, M. (2017). Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study. BMC Cancer, 17(1), 2. doi:10.1186/s12885-016-3013-7
dc.identifier.issn 1471-2407
dc.identifier.uri https://hdl.handle.net/20.500.11815/305
dc.description.abstract Background Except for overall survival, whether or not waiting time for treatment could influences other domains of cancer patients’ overall well-being is to a large extent unknown. Therefore, we performed this study to determine the effect of waiting time for cancer treatment on the mental health of patients with esophageal or gastric cancer. Methods Based on the Swedish National Quality Register for Esophageal and Gastric Cancers (NREV), we followed 7,080 patients diagnosed 2006–2012 from the time of treatment decision. Waiting time for treatment was defined as the interval between diagnosis and treatment decision, and was classified into quartiles. Mental disorders were identified by either clinical diagnosis through hospital visit or prescription of psychiatric medications. For patients without any mental disorder before treatment, the association between waiting time and subsequent onset of mental disorders was assessed by hazard ratios (HRs) with 95% confidence interval (CI), derived from multivariable-adjusted Cox model. For patients with a preexisting mental disorder, we compared the rate of psychiatric care by different waiting times, allowing for repeated events. Results Among 4,120 patients without any preexisting mental disorder, lower risk of new onset mental disorders was noted for patients with longer waiting times, i.e. 18–29 days (HR 0.86; 95% CI 0.74-1.00) and 30–60 days (HR 0.79; 95% CI 0.67-0.93) as compared with 9–17 days. Among 2,312 patients with preexisting mental disorders, longer waiting time was associated with more frequent psychiatric hospital care during the first year after treatment (37.5% higher rate per quartile increase in waiting time; p for trend = 0.0002). However, no such association was observed beyond one year nor for the prescription of psychiatric medications. Conclusions These data suggest that waiting time to treatment for esophageal or gastric cancer may have different mental health consequences for patients depending on their past psychiatric vulnerabilities. Our study sheds further light on the complexity of waiting time management, and calls for a comprehensive strategy that takes into account different domains of patient well-being in addition to the overall survival.
dc.description.sponsorship This study was partly supported by the Swedish Cancer Society (grant No: CAN 2014/417).
dc.format.extent 2
dc.language.iso en
dc.publisher Springer Nature
dc.relation.ispartofseries BMC Cancer;17(1)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Mental disorder
dc.subject Gastric cancer
dc.subject Esophageal cancer
dc.subject Cohort study
dc.subject Cancer treatment
dc.subject Waiting time
dc.subject Geðraskanir
dc.subject Magakrabbamein
dc.subject Rannsóknir
dc.subject Krabbameinslækningar
dc.subject Krabbamein
dc.title Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study
dc.type info:eu-repo/semantics/article
dcterms.license This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.description.version Peer Reviewed
dc.identifier.journal BMC Cancer
dc.identifier.doi 10.1186/s12885-016-3013-7
dc.contributor.department Miðstöð í lýðheilsuvísindum (HÍ)
dc.contributor.department The Centre of Public Health Sciences (UI)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu